Claim Missing Document
Check
Articles

Found 2 Documents
Search

JELLY HYPERTENSION MEDICINE FOR THE ELDERLY: FRESH AS A PRACTICAL PREVENTION MEASURE: JELLY OBAT HIPERTENSI UNTUK LANSIA SEGARAN SEBAGAI UPAYA PENCEGAHAN PRAKTIS Prasetyani Putri, Mardiana; Arshy Prodyanatasari; Mely Purnadianti
WISDOM : Jurnal Pengabdian Kepada Masyarakat Wisdom Vol. 2 No. 2 (2025): JPKM WISDOM 4, 2025
Publisher : PT. ROCE WISDOM ACEH

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.71275/wisdom.v2i2.102

Abstract

This community service activity aims to empower the elderly in Segaran Village, Wates District, KediriRegency, through the innovation of making ready-to-consume medicinal jelly as a practical effort to prevent hypertension. Hypertension is a common chronic health problem in the elderly population and can increase the risk of morbidity and mortality. Prevention interventions that are easy to implement and well-received by older people are urgently needed. The implementation method of this activity includes socialisation about hypertension and the importance of prevention, training in making medicinal jelly using natural ingredients with antihypertensive potential, and assistance with packaging and storing products. This activity involves the active participation of older people at every stage. The expected results of this activity are increased knowledge of the elderly about preventing hypertension, skills in making medicinal jelly independently, and the availability of practical natural supplement alternatives that have the potential to support blood pressure control. The medicinal jelly product produced is expected to be a sustainable preventive solution that contributes to improving the quality of life for older people in Segaran Village. Evaluation of the activity will be carried out through observation, interviews, and measuring the level of participant satisfaction.
The Antibiotic Sensitivity Test Comparison of Erythromycin and Ciprofloxacin Against Pseudomonas sp. Bacteria in Diabetic Foot Ulcers: Perbandingan Uji Sensitivitas Antibiotik Erythromycin dan Ciprofloxacin Terhadap Bakteri Pseudomonas sp. Pada Ulkus Kaki Diabetikum Agustina, Novia; Purnadianti.,S.St.,M.Si, Mely; Prasetyani Putri, Mardiana; Prodyantasari4, Arshy; Ngalimatul Hikmah, Rizza
Jurnal Sintesis: Penelitian Sains, Terapan dan Analisisnya Vol 6 No 2 (2025): Desember 2025
Publisher : Fakultas Sains, Teknologi, dan Analsisi Institut ilmu Kesehatan Bhakti Wiyata

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.56399/jst.v6i2.351

Abstract

Diabetes mellitus (DM) is a metabolic disease characterized by hyperglycemia due to abnormal insulin secretion and function. One of the complications of diabetes mellitus is peripheral neuropathy, which can lead to diabetic ulcers. Diabetic ulcers can be caused by bacterial infections, specifically from Pseudomonas sp. Antibiotic therapy for diabetic ulcers, particularly those resulting from Pseudomonas sp. infections, has frequently encountered resistance. Therefore, it is necessary to test the sensitivity of Pseudomonas sp. bacteria to the antibiotics used for treatment. This study aims to determine the sensitivity of Pseudomonas sp. from the ulcers of DM patients to the antibiotics erythromycin and ciprofloxacin. Pseudomonas bacteria were isolated from ulcer specimens using cetrimide media, followed by a sensitivity test using the diffusion method on Mueller Hinton Agar medium at 37°C for 24 hours. The research data were analyzed using the comparative Mann-Whitney statistical test. The results showed that Pseudomonas sp. was sensitive to erythromycin by 21% and to ciprofloxacin by 29%, while resistance was 79% for erythromycin and 71% for ciprofloxacin. The statistical results indicated no significant difference between the antibiotics erythromycin and ciprofloxacin (Asymp. Sig. value 0.668). The findings of this study can provide information on the phenomenon of Pseudomonas sp. resistance to erythromycin and ciprofloxacin, offering a basis for evaluating future treatment therapies with further testing. Keywords: Pseudomonas sp, Ulcer, Erythromycin, Ciprofloxacin